Royal Bank Of Canada Qiagen N.V. Transaction History

Royal Bank Of Canada

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$35.55 - $43.57 $174,763 - $214,190	-4,916 Reduced 26.79%	13,431 $583,000
Q3 2023 Nov 14, 2023	BUY	$39.13 - $47.24 $448,234 - $541,134	11,455 Added 166.21%	18,347 $743,000
Q2 2023 Aug 14, 2023	SELL	$43.93 - $46.76 $352,933 - $375,669	-8,034 Reduced 53.83%	6,892 $310,000
Q1 2023 May 15, 2023	BUY	$45.29 - $50.76 $222,736 - $249,637	4,918 Added 49.14%	14,926 $685,000
Q4 2022 Feb 14, 2023	SELL	$41.91 - $50.48 $1.54 Million - $1.86 Million	-36,803 Reduced 78.62%	10,008 $499,000
Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $1.45 Million - $1.79 Million	35,449 Added 312.0%	46,811 $1.93 Million
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $40,831 - $47,281	-950 Reduced 7.72%	11,362 $535,000
Q1 2022 May 16, 2022	SELL	$42.23 - $54.3 $154,477 - $198,629	-3,658 Reduced 22.91%	12,312 $602,000
Q4 2021 Feb 14, 2022	SELL	$50.62 - $56.47 $5.87 Million - $6.55 Million	-115,954 Reduced 87.89%	15,970 $887,000
Q3 2021 Nov 15, 2021	BUY	$46.55 - $56.83 $89,841 - $109,681	1,930 Added 1.48%	131,924 $6.82 Million
Q2 2021 Aug 16, 2021	BUY	$46.28 - $52.75 $6.02 Million - $6.86 Million	129,994 New	129,994 $6.29 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.4B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.